seqnanswers thread : http://seqanswers.com/forums/showthread.php?t=16709
Just how good this piece of equipment is unknown. Regardless, the race to the $1K genome may be in the final lap.
Illumina is their main competitor. Looks like ILMN stock took a hit but recovered quickly : http://finance.yahoo.com/q/bc?s=ILMN+Basic+Chart&t=5d , so I guess the market is unconvinced.